國(guo)(guo)藥(yao)(yao)集團三益藥(yao)(yao)業(蕪(wu)湖)有(you)限(xian)公司(si)(si),成(cheng)立于2012年12月,省(sheng)級高新技術企業,是上(shang)海(hai)現代制藥(yao)(yao)股份有(you)限(xian)公司(si)(si)(股票(piao)代碼600420)和國(guo)(guo)藥(yao)(yao)控股股份有(you)限(xian)公司(si)(si)(股票(piao)代碼:01099.HK)合資(zi)的控股子公司(si)(si),是中國(guo)(guo)醫藥(yao)(yao)集團內專業的外用藥(yao)(yao)生產(chan)企業。
中(zhong)國醫(yi)藥集團是由(you)國務(wu)院國資委(wei)直接(jie)管理(li)的中(zhong)國規模較大、產(chan)(chan)業(ye)鏈較全、綜合實(shi)力較強(qiang)的醫(yi)藥健康產(chan)(chan)業(ye)集團。以預防治療和診斷護(hu)理(li)等(deng)健康相關產(chan)(chan)品的分銷、零售(shou)、研發及生(sheng)產(chan)(chan)為(wei)主業(ye)。
上(shang)海現代制藥股份有(you)限(xian)公司成(cheng)(cheng)立于1996年(nian),2004年(nian)6月16日在上(shang)海證券交易所上(shang)市,2010年(nian)4月進入中國醫藥集團(tuan)總公司,2016年(nian)11月,完成(cheng)(cheng)國藥集團(tuan)化藥工業整合。
國(guo)(guo)藥(yao)控股(gu)股(gu)份有限公(gong)司是中國(guo)(guo)醫(yi)藥(yao)集團總公(gong)司所屬核心(xin)企業,成立(li)于(yu)2003年(nian)1月,2009年(nian)9月23日在香港上市(股(gu)票代碼:01099.HK),系中國(guo)(guo)較大的藥(yao)品、醫(yi)療保健產品分銷商及供應(ying)鏈服務(wu)提供商。
公(gong)(gong)(gong)(gong)司(si)(si)(si)前身為蕪(wu)湖(hu)三(san)(san)益信成(cheng)(cheng)制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)。2012年(nian)6月在蕪(wu)湖(hu)市政府的支持(chi)(chi)下,國(guo)藥控股(gu)(gu)(gu)(gu)(gu)與蕪(wu)湖(hu)三(san)(san)益信成(cheng)(cheng)制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)和蕪(wu)湖(hu)三(san)(san)益制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)簽署(shu)股(gu)(gu)(gu)(gu)(gu)權合(he)作協議(yi),控股(gu)(gu)(gu)(gu)(gu)蕪(wu)湖(hu)三(san)(san)益信成(cheng)(cheng)制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si),吸(xi)收(shou)合(he)并蕪(wu)湖(hu)三(san)(san)益制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)資產而(er)成(cheng)(cheng)。2016年(nian)10月20日,根據中(zhong)國(guo)醫藥集團工(gong)業整合(he)戰略(lve)布署(shu),公(gong)(gong)(gong)(gong)司(si)(si)(si)由上海現代制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)與國(guo)藥控股(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)份有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)共同持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)。上海現代制(zhi)(zhi)藥有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)比(bi)例為51%,國(guo)藥控股(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)份有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)比(bi)例為49%。
公司總部(bu)位于安徽省(sheng)蕪湖市(shi)生(sheng)物藥(yao)業(ye)科技園(九華北路175號),同時擁(yong)有長江路生(sheng)產(chan)(chan)基(ji)地(di)。總占地(di)面積(ji)118畝,公司主要生(sheng)產(chan)(chan)皮膚外用藥(yao)及眼科用藥(yao)兩大類產(chan)(chan)品,產(chan)(chan)品行銷全國29個省(sheng)、市(shi)、自(zi)治(zhi)區,年銷售(shou)收入超(chao)億元。